Table 1

Baseline patient characteristics

HDWL
OR (95% CI)
HDV
OR (95% CI)
Fisher’s exact p value
Age in years, median (IQR, p25–p75)53.7 (20 to 79)54.3 (21 to 80)0.786
Sex (M:F)46:4855:390.242
Type of colitis, n (%)
 UC60 (64)69 (73)0.204
 Concurrent primary sclerosing cholangitis1 (1)1 (1)
 Crohn’s colitis33 (35)24 (26)0.204
Distribution of colitis, n (%)
 Left sided15 (16)23 (24)0.203
 Subtotal/total79 (84)71 (76)0.203
 Duration of illness in years, median (IQR, p25–p75)17.0 (13 to 27.5)18.0 (13.3 to 25.8)0.635
 Left sided19.0 (15.5 to 22.5)23.0 (17.5 to 26.0)
 Subtotal/total17.0 (12.5 to 28.0)16.0 (12.5 to 25.5)
Therapy, n (%)
 Steroids2 (2)1 (1)1
 ASA76 (81)80 (85)0.561
 Immunosuppressant29 (31)27 (29)0.873
 Biologics9 (10)6 (6)0.592
  • ASA, aminosalicylic acid; HDV, high-definition virtual chromoendoscopy; HDWLE, high-definition white light.